Could Eli Lilly’s Next Weight Loss Drug Waylay Wegovy — and Even Zap Zepbound?
After losing its market edge to Eli Lilly (NYSE: LLY) despite its first-mover advantage in weight-loss drugs, Novo…
Fitness coach warns ‘95% of people who lose weight gain it back’, reveals 11 common nutrition habits to follow
While weight loss is an uphill battle, maintaining your healthy weight goals and avoiding weight regain can be…
She Lost 60 Pounds on the Mayo Clinic Diet—Here’s How It Worked
Weight that creeps up through adulthood is a challenge—but for individuals who’ve experienced it since childhood, the idea…
Study shows simple diet method means you lose more weight and keep it off
Major new international research showed how much more effective the system isNeil Shaw Assistant Editor (Money and Lifestyle)…
Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss
Eli Lilly and Co. (NYSE:LLY) on Wednesday released detailed findings from two late-stage obesity studies showing patients were…
She Lost 60 Pounds on the Mayo Clinic Diet—Here’s How It Worked
Weight that creeps up through adulthood is a challenge—but for individuals who’ve experienced it since childhood, the idea…
Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO2026
Novo Nordisk A/S Almost a third of adults taking Wegovy® pill (oral semaglutide 25 mg) were early responders…
Obesity drugs and surgery linked to greater fat-free mass loss
A new systematic review and meta-analysis of studies presented at this year’s European Congress on Obesity in Istanbul,…
Novo Nordisk’s high-dose Wegovy touts near 28% weight loss in early responders
Novo Nordisk has shared new data that suggests a higher dose version of its blockbuster weight loss drug,…
New pill sees people lose fifth of body weight in major study
The tablet is not yet available in the UK but was approved in the US in DecemberNeil Shaw…
Could GLP-1 drugs help breast cancer patients live longer?
A major real-world study links GLP-1 receptor agonists to improved survival and lower recurrence risk in women with…
GLP-1 drugs may reshape how brain values rewarding foods
A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does…